Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chemotherapy-induced Peripheral Neuropathy: early-phase trial registry
15 of 30 indexed Chemotherapy-induced Peripheral Neuropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #519 of 28,707 conditions by registered trial count.
30 US clinical trials · 15 currently recruiting · #519 of 28,707 conditions by registered trial count
Chemotherapy-induced Peripheral Neuropathy: 30 US clinical trials tracked, 15 recruiting.
Chemotherapy-induced Peripheral Neuropathy is the subject of 30 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 4 of these trials.
Enrollment posture brief
Registry condition chemotherapy-induced-peripheral-neuropathy
OPEN 15 | RECR 50% | LATE 0 | EARLY 7 | RANK #519 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Chemotherapy-induced Peripheral Neuropathy lists 15 open slots (50% of 30 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chemotherapy-induced Peripheral Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chemotherapy-induced Peripheral Neuropathy is recruiting above its size-band peers.
15 of 30 indexed trials (50%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Chemotherapy-induced Peripheral Neuropathy trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 4 of 30 trials (13.3%). 24 distinct sponsors appear on at least one study for this condition label.
-
Most Chemotherapy-induced Peripheral Neuropathy trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 30 trials that report a genuine target (sentinel values excluded). 20 of those (66.7%) plan for fewer than 100 participants.
-
Chemotherapy-induced Peripheral Neuropathy research is mostly interventional.
24 interventional and 6 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
30 total, page 1 of 1
International CIPN Assessment and Validation Study
University of Milano Bicocca
NCT04633655
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
University of Vermont
NCT04763356
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
NCT04560673
Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
NCT06945380
Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
Duke University
NCT06139458
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
NCT06731894
Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy
Case Comprehensive Cancer Center
NCT07219472
Cryocompression for CIPN
Dana-Farber Cancer Institute
NCT07064798
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
University of Michigan Rogel Cancer Center
NCT07365007
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
M.D. Anderson Cancer Center
NCT06389721
Physiologic Measure of VIPN
Children's National Research Institute
NCT04786977
VGAIT for Chemotherapy-induced Peripheral Neuropathy
Massachusetts General Hospital
NCT07177820
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
Yale University
NCT07019259
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
NCT05411523
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study
M.D. Anderson Cancer Center
NCT06162403
Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)
AlgoTherapeutix
NCT05593614
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT04917796
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT05121558
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
University of Rochester NCORP Research Base
NCT04888988
PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy
Academic and Community Cancer Research United
NCT05246670
A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy
WinSanTor
NCT05488873
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
Donna Hammond, PhD
NCT04112641
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
University of Oklahoma
NCT04959929
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
Wake Forest University Health Sciences
NCT04156802
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy
OHSU Knight Cancer Institute
NCT04170075
Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)
H. Lee Moffitt Cancer Center and Research Institute
NCT04092764
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
Bexion Pharmaceuticals
NCT05291286
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
M.D. Anderson Cancer Center
NCT04239976
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NeuraLace Medical
NCT05935956
Spinal Cord Stimulation in Chemotherapy Induced Neuropathy
Prisma Health-Upstate
NCT03764514
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Chemotherapy-induced Peripheral Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chemotherapy-induced Peripheral Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chemotherapy-induced Peripheral Neuropathy page
30 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Chemotherapy-induced Peripheral Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Chemotherapy-induced Peripheral Neuropathy trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chemotherapy-induced Peripheral Neuropathy condition card totals 30 registered trials; most-linked intervention Quality-of-Life Assessment; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.